ArticleCancers2026

The Global Immune-Nutrition-Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab.

Tara Coreanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.